首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of huntingtons disease

缩写:

ISSN:1879-6397

e-ISSN:1879-6400

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引475
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
N Ahmad Aziz,Daniel Claassen,Åsa Petersén et al. N Ahmad Aziz et al.
A recent retrospective analysis of Enroll HD data suggesting β-blockers slow Huntington's disease progression has triggered patient demand but requires caution. The findings rely solely on small observational subsets and are vulnerable to ...
Mariana Sierra,Rachael Powers,Nikolas Grotewold et al. Mariana Sierra et al.
Two- and three-dimensional (2D and 3D) cell models derived from human stem cells have shed light on a wide range of molecular and cellular features of Huntington's disease (HD). Here we review the use of human stem cell-derived models to ex...
Romana Konvalinkova,Martin Srp,Kristyna Doleckova et al. Romana Konvalinkova et al.
BackgroundAs Huntington's disease (HD) progresses, it impairs airway protection, increasing the risk of aspiration pneumonia-the leading cause of death in HD. Although voluntary peak cough flow (vPCF) assesses cough effectiveness, its clini...
Katharine Huynh,Nellie Georgiou-Karistianis,Amit Lampit et al. Katharine Huynh et al.
BackgroundComputerized cognitive training (CCT) has been found to improve cognition by altering functional activity and functional connectivity of brain networks in people with and without cognitive impairment. The effects of CCT on functio...
Mena Farag,Sarah J Tabrizi,Edward J Wild Mena Farag
In this edition of the Huntington's Disease Clinical Trials Update, we expand on the launch of the phase II/III clinical trial of SKY-0515 from Skyhawk Therapeutics and the phase I/II clinical trial of SPK-10001 from Spark Therapeutics. We ...
Mallory R Shin,Marco M Hefti Mallory R Shin
Huntington's disease (HD) is classically characterized as a late-onset neurodegenerative disorder of adulthood caused by CAG expansion in the HTT gene. However, mounting evidence from both human and experimental studies suggests that both w...
Jordan L Schultz,Peg C Nopoulos Jordan L Schultz
Recent findings suggest that neurodevelopment plays a critical role in Huntington's Disease (HD) pathogenesis. This review integrates data from human studies of children and young adults at risk for HD (the Kids-HD study) with the theory of...
Nicolò Zarotti,Alice Storey,Sarah Lloyd et al. Nicolò Zarotti et al.
BackgroundDeficits of emotion recognition have received increasing attention in people with Huntington's disease (HD) in the three decades since the discovery of the HD gene. However, the characterisation of such deficits across different d...
Gianna M Fote,Nicolette R McClure,Robert M Bragg et al. Gianna M Fote et al.
BackgroundThe HTT protein, mutated in Huntington's disease, is expressed throughout the body, and loss of HTT function as an autophagic scaffold may affect tissues and cellular processes. These processes include lipid metabolism potentially...
Behnaz Nateghi,Mohamed Lala Bouali,Zineb Bouredji et al. Behnaz Nateghi et al.
Background: Huntington's disease (HD) is a progressive neurodegenerative disorder primarily affecting the central nervous system (CNS). However, emerging evidence suggests that peripheral tissues, including skeletal muscle and bone, also un...